The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
'Tell them at the AGM' - yawn.
They have my mobile number and email address. I can't do anymore. I'm not wasting the best of £500 to attend an AGM to be told 'communications will improve' and 'we are suffering too on £350k salaries'
Trials to start end of month?
Fruits - let's be honest here, we've not had any positive news for over nearly 2.5 years.
The drug hasn't been trialled on a patient since Nov 2021.
The company won't update us or even talk to us.
Trials to start next month? Really?
I would love to find something positive.
Attending conferences is something this company has done for the last 20 years.
Posting a link about something in America that might happen later this year isn't news either.
Absolutely nothing to get excited about.
Every link or 'update' either contains the words 'anticipated to start...' or 'subject to...'
We are not even linked to the article and the plan is to start BARDA next gen later this year.
No update from the company to tells us BARDA have spoken to us.
It's just guess work from Tommy.
Yes, smiling at 6p. Fantastic.
Trolls? Marsden has created this 'hate' culture towards the company.
Based on the current position of the company, it only points to failure.
Do I want the company to succeed? Yes.
Do I think the board of directors hate shareholders? Yes.
TP - the reason was I remain 'invested' is I am locked into this company following a 97% share price collapse. I have no choice.
I have no idea why new investors would want to be 'part' of this company.
No products
No trials
No communications
No revenue
It also appears the board of directors don't value their shareholders.
Genuinely, help me out if you can. What are the positives?
Great post Spacman. Some on here think trials to start end of Q1 2024 is on target.
The target start date for trials started with the RNS in April 22, then end of 2023 and now end of Q1 2024.
My view based on the silence from the company, considering the above and 97% in share price, trials will be delayed again!
Cave door has to open shortly
Agreed Doc.
Month 5 of the year and god knows how many millions spent in overheads and the only news we have is the company attended a presentation in Scotland a couple of weeks ago.
Does our CEO genuinely think that is how to treat shareholders following a 97% drop in share price whilst they live off the £85m fundraise.
Gunto - you are trying really hard to luck clever.
The majority of the TFG investment was pre phase 3 results. They bought between £2 and say £1.00. The share price is now c. 6p.
The interview with Reade Griffith (I believe is Oct 2022) after trial failure. That doesn't tell you anything about how Synairgen will turn this mess around.
I don't understand the link the between one interview which means everything will come good.